Mark Iwicki
@markiwicki
Executive Officer, Director
Building KALA BIO, Inc. as Executive Officer, Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Akero Therapeutics, Inc. was founded in 2017 and has no closure on record.
Named alongside
- Aaron KantoffDirector
- Aaron RoystonDirector
- Andrew ChengExecutive Officer, Director
- Graham WalmsleyDirector
- Jonathan YoungExecutive Officer
- Kevin BittermanDirector
- Andrew I. KovenDirector
- Andrew L. KovenDirector
- Avi MinkowitzExecutive Officer, Director
- Brendan PurdyDirector
- C. Daniel MyersDirector
- Chaim BergerDirector
- Charles B. McDermottExecutive Officer
- Chen B. YuDirector
- Akihisa AkaoDirector
- Amit D. MunshiDirector
- Amit MunshiDirector
- Anand VaradanDirector
- Christopher CabellDirector
- Christopher D. CabellDirector
- Christopher J. CabellDirector
- David HavaChief Scientific Officer
Contribution
Mark's ideas, decisions and failures appear here once this profile is claimed.
Companies
- KALA BIO, Inc.Pharmaceutical Preparations; listed on Nasdaq as KALA; filing with the SEC since 2009Executive Officer, Director · Pharmaceuticals · ARLINGTON, United States
- Akero Therapeutics, Inc.Pharmaceutical Preparations; filing with the SEC since 2018Director · Pharmaceutical Preparations · South San Francisco, United States · Founded 2017
- Pulmatrix, Inc.Pharmaceutical Preparations; formerly Ruthigen, Inc.; listed on Nasdaq as PULM; filing with the SEC since 2013Director · Biotechnology · FRAMINGHAM, United States